Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Form 8.3 - Renishaw PLC

27 May 2021 11:17

RNS Number : 0565A
Baillie Gifford & Co.
27 May 2021
Β 

FORMΒ 8.3

Β 

PUBLICΒ OPENINGΒ POSITIONΒ DISCLOSURE/DEALINGΒ DISCLOSUREΒ BY

AΒ PERSONΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β OR MORE

RuleΒ 8.3Β ofΒ theΒ TakeoverΒ CodeΒ (theΒ "Code")

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Renishaw Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26 May 2021

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevant securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ in 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (as appropriate)Β for eachΒ additionalΒ classΒ of relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offeree toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealingΒ (ifΒ any)

Β 

Class of relevant security:

20p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

4,907,842

6.74

(2) Cash-settled derivatives:

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Β 

TOTAL:

4,907,842

6.74

Β 

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ be disclosed.

Β 

Details Β of Β any Β open Β stock-settled Β derivative Β positions Β (including Β traded Β options), Β or agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ Supplemental FormΒ 8Β (OpenΒ Positions).

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employee options)

Β 

Class of relevant security in relation to

which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. Β DEALINGSΒ (IFΒ ANY)Β BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ have beenΒ dealingsΒ in moreΒ than oneΒ classΒ of relevantΒ securitiesΒ of theΒ offerorΒ or offeree named inΒ 1(c), copyΒ table 3(a), (b), (c)Β orΒ (d)Β (asΒ appropriate)Β forΒ each additionalΒ class ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) Β PurchasesΒ andΒ sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

20p Ordinary

Sale

311

54.681

20p Ordinary

Sale

708

54.780

20p Ordinary

Purchase

1,851

54.628

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Β 

DetailsΒ ofΒ anyΒ indemnityΒ orΒ optionΒ arrangement,Β orΒ anyΒ agreementΒ orΒ understanding, formalΒ orΒ informal,Β relatingΒ toΒ relevantΒ securitiesΒ whichΒ mayΒ beΒ anΒ inducementΒ toΒ deal orΒ refrainΒ fromΒ dealingΒ enteredΒ intoΒ byΒ theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ party toΒ theΒ offerΒ orΒ anyΒ personΒ actingΒ inΒ concertΒ withΒ aΒ partyΒ toΒ theΒ offer:

IrrevocableΒ commitmentsΒ andΒ lettersΒ of intentΒ shouldΒ notΒ be included.Β IfΒ thereΒ areΒ noΒ such agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

None

Β 

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

DetailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understanding,Β formalΒ orΒ informal,Β between theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ otherΒ personΒ relatingΒ to:

(i)Β theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option;Β or

(ii)Β theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ which anyΒ derivativeΒ isΒ referenced:

IfΒ thereΒ areΒ noΒ suchΒ agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

Β 

None

Β 

Β 

(c) Attachments

Β 

IsΒ aΒ SupplementalΒ FormΒ 8 (OpenΒ Positions)Β attached? NO

Β 

Β 

Β 

Date of disclosure:

27.05.2021

Contact name:

Alan Gilliland-Patterson

Telephone number:

0131 275 3779

Β 

PublicΒ disclosuresΒ underΒ RuleΒ 8Β ofΒ theΒ CodeΒ mustΒ beΒ madeΒ toΒ aΒ RegulatoryΒ Information

Service.

Β 

TheΒ Panel'sΒ MarketΒ SurveillanceΒ UnitΒ isΒ availableΒ forΒ consultationΒ inΒ relationΒ toΒ theΒ Code's disclosureΒ requirementsΒ on +44Β (0)20Β 7638Β 0129.

Β 

TheΒ CodeΒ canΒ be viewedΒ onΒ the Panel'sΒ websiteΒ atΒ Β www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETSEMFSWEFSEFI
Date   Source Headline
25th Jul 20182:00 pmRNSDirectorate Change
4th Jul 20187:00 amRNSNotice of Results
13th Jun 20181:00 pmRNSDirector Declaration
24th May 20183:00 pmRNSVoting Arrangement
9th May 20187:00 amRNSTrading Statement
23rd Apr 20182:00 pmRNSDirector Declaration
9th Apr 20188:42 amRNSDirector/PDMR Shareholding
19th Mar 201812:00 pmRNSNotice of Investor Day
26th Jan 20181:27 pmRNSDirector/PDMR Shareholding
25th Jan 20185:03 pmRNSDirector/PDMR Shareholding
25th Jan 20187:00 amRNSHalf-year Report
24th Jan 20183:12 pmRNSChange in Directors' Responsibilities
11th Jan 20187:00 amRNSNotice of Results
20th Oct 20172:20 pmRNSResult of AGM
25th Aug 20177:00 amRNSAnnual Financial Report and Directorate Change
27th Jul 20177:00 amRNSFinal Results
10th Jul 201711:00 amRNSNotice of Results
26th May 20177:00 amRNSRemuneration policy 2017
10th May 20177:00 amRNSTrading Statement
31st Mar 20179:00 amRNSNotice of Investor Day
26th Jan 20177:00 amRNSHalf-year Report
9th Jan 201710:00 amRNSNotice of Results
13th Oct 20163:20 pmRNSResult of AGM
13th Oct 201610:54 amRNSTrading Statement
26th Aug 20169:00 amRNSAnnual Financial Report
27th Jul 20167:00 amRNSFinal Results
7th Jul 201610:00 amRNSNotice of Results
11th May 20167:00 amRNSTrading Statement
24th Mar 20167:00 amRNSTrading Statement
23rd Mar 201610:00 amRNSDate of Investor Day
25th Feb 20162:52 pmRNSDisclosure of Home Member State
28th Jan 20167:00 amRNSHalf Yearly Report
13th Jan 20161:39 pmRNSNotice of Results
15th Dec 20152:11 pmRNSDirector - change in responsibilities
15th Oct 20154:59 pmRNSResult of AGM
15th Oct 201510:31 amRNSTrading Statement
28th Aug 20157:00 amRNSAnnual Financial Report
29th Jul 20157:00 amRNSFinal Results
15th Jul 20152:06 pmRNSNotice of Results
18th May 201511:04 amRNSDirector/PDMR Shareholding
13th May 20157:00 amRNSTrading Statement
17th Mar 20157:43 amRNSDate of Investor day
29th Jan 20157:00 amRNSHalf Yearly Report
13th Jan 20153:08 pmRNSNotice of Results
6th Jan 20154:14 pmRNSTrading Statement
17th Nov 20147:00 amRNSStatement re Relationship agreement
11th Nov 20147:00 amRNSTrading Statement
27th Oct 20147:00 amRNSTrading Statement
16th Oct 20142:55 pmRNSResult of AGM
16th Oct 201410:04 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.